TNF Biosimilars Market is expected to grow at a 16.5% CAGR during the forecast period for 2025-2034. Tumor necrosis factors are a group of cytokines that are secreted by macrophages and may induce cell death of certain tumor cell lines, which leads to inflammation. TNF inhibitors are the drug that stops inflammation. They are mainly indicated for the treatment of rheumatoid arthritis, psoriasis, inflammatory bowel disease, anklyosing Spo...
Report ID: 1072 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
Global Temporary Healthcare Staffing Market Size is valued at USD 61.4 Bn in 2023 and is predicted to reach USD 85.3 Bn by the year 2031 at a 4.35% CAGR during the forecast period for 2024-2031. Key Industry Insights & Findings from the Report: The expansion of the temporary healthcare staffing industry is propelled by the increasing scarcity of proficient medical practitioners, in addition to the cost-effectiveness linked to te...
Report ID: 2401 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
Bruton Tyrosine Kinase (BTK) Inhibitors Market Size is predicted to grow with a 15.0% CAGR during the forecast period for 2025-2034. Non-receptor tyrosine kinase inhibitors that target B-cell receptors are called Bruton's tyrosine kinase (BTK) inhibitors to modulate B-cell signalling, proliferation, growth, and differentiation. B-cell leukaemia, lymphomas, haematological malignancies, and graft versus host disease are treated with Bruton's tyr...
Report ID: 1242 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
Antibody Purification Services Market is expected to grow at an 10.5% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: Effective and targeted therapies are becoming more and more necessary due to the rising incidence of infectious and chronic illnesses. Pharmaceutical and biotechnology businesses are outsourcing antibody manufacturing and purification services more frequently in an e...
Report ID: 1248 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
CD Targeted Bispecific Antibody Market is expected at an 14.5% CAGR during the forecast period for 2025-2034. InsightAce Analytic’s “Global CD Targeted Bispecific Antibody Market Research Report 2023” is a comprehensive analysis, forecast, market dynamics and major trends report covering key market data on the CD Targeted Bispecific Antibody target type segments. This market research report provides market estimation and fore...
Report ID: 1144 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 160
Infliximab Biosimilar Market Size is valued at XX Million in 2024 and is predicted to reach XX Million by the year 2034 at an XX % CAGR during the forecast period for 2025-2034. Infliximab is chimeric anti-TNF monoclonal antibody approved for the treatment of Chron’s Disease. It is also approved for the treatment of other autoimmune diseases such as Psoriasis, rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, and others. It is...
Report ID: 1060 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
Filgrastim Biosimilars Market Size is predicted to expand with a 8.5% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: Governments around the world are promoting the use of biosimilars through various initiatives aimed at enhancing affordability and access. Filgrastim biosimilars have been shown to be effective and safe for managing neutropenia in cancer patients, which enhances their ado...
Report ID: 1076 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 175
Trastuzumab Biosimilar Market is expected to grow at a 25.0 % CAGR during the forecast period for 2025-2034. Trastuzumab is a recombinant DNA-derived humanized monoclonal antibody that binds to human epidermal growth factor receptor 2 (HER2). HER2 is over expressed in some types breast cancer cells hence, trastuzumab is mainly indicated for the treatment of HER2 positive breast cancer as well as it is also approved for the treatment of metasta...
Report ID: 1080 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
Oncolytic Virus Therapy Market is estimated to grow at a 24.5% CAGR during the forecast period for 2025-2034. In recent decades, the healthcare burden of Cancer increasing rapidly with an increasing incidence rate. The massive investment in research and development has been implemented to find innovative drugs/therapy/Immuno oncology solutions to cure cancer. Some of them gaining interest include oncolytic viruses therapy, stem cell therapies,...
Report ID: 1087 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
Therapeutic Plasma Exchange Market is expected to grow at an 5.5% CAGR during the forecast period for 2025-2034. Plasma exchange is a biological procedure that removes large-molecular-weight substances such as harmful antibodies from the plasma. In this procedure, a large portion of plasma containing abnormal matter and toxins are removed from the components of WBCs, RBCs, and platelets and then replaced with replacement fluid, like fresh froz...
Report ID: 1120 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
Pharmaceuticals